American International Group’s RAPT Therapeutics RAPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,820
Closed -$131K 2097
2024
Q1
$131K Sell
1,820
-15
-0.8% -$2.09K ﹤0.01% 2372
2023
Q4
$365K Sell
1,835
-8
-0.4% -$990 ﹤0.01% 1835
2023
Q3
$245K Buy
1,843
+66
+4% +$10.8K ﹤0.01% 2012
2023
Q2
$266K Sell
1,777
-22
-1% -$3.43K ﹤0.01% 2014
2023
Q1
$264K Buy
1,799
+245
+16% +$49.6K ﹤0.01% 1958
2022
Q4
$246K Buy
1,554
+11
+0.7% +$1.76K ﹤0.01% 2024
2022
Q3
$297K Buy
1,543
+22
+1% +$4.16K ﹤0.01% 1913
2022
Q2
$222K Buy
1,521
+198
+15% +$26.4K ﹤0.01% 2121
2022
Q1
$233K Sell
1,323
-93
-7% -$17.6K ﹤0.01% 2149
2021
Q4
$416K Sell
1,416
-42
-3% -$11.2K ﹤0.01% 1935
2021
Q3
$362K Buy
1,458
+199
+16% +$52.6K ﹤0.01% 2061
2021
Q2
$320 Buy
1,259
+460
+58% +$85.9K ﹤0.01% 2213
2021
Q1
$142 Buy
799
+2
+0.3% +$330 ﹤0.01% 2541
2020
Q4
$126 Sell
797
-23
-3% -$5K ﹤0.01% 2539
2020
Q3
$211K Sell
820
-19
-2% -$4.22K ﹤0.01% 2114
2020
Q2
$195K Buy
839
+707
+536% +$109K ﹤0.01% 2134
2020
Q1
$22K Buy
132
+10
+8% +$2.28K ﹤0.01% 2914
2019
Q4
$27K Buy
+122
New +$22.5K ﹤0.01% 2984

Other funds holding RAPT

American International Group's RAPT Position: Q2 2024 in Review

American International Group sold out of RAPT Therapeutics (RAPT) in Q2 2024, closing a stake of 1,820 shares — an estimated $131K sold.

American International Group first reported a position in RAPT in Q4 2019 and held it in 18 quarters. The position peaked at $416K in Q4 2021. 103 funds tracked by Wall St. Rank hold RAPT as of Q2 2024.

  • American International Group reported no remaining RAPT Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 1,820 RAPT Therapeutics shares in Q2 2024, an estimated $131K.
  • American International Group first reported a position in RAPT Therapeutics in Q4 2019 and held it in 18 quarters.
  • American International Group's RAPT Therapeutics position peaked at $416K in Q4 2021.
  • 103 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.